Report

Medicines in Development for Skin Diseases

New Medicines in Development for Skin Diseases

PhRMA April 9, 2013

America’s biopharmaceutical research companies are currently developing 277 medicines to help the more than 100 million Americans—one-third of the U.S. population—afflicted with at least one skin disease, ranging from acne to melanoma. All of the medicines are either in clinical trials or awaiting review by the U.S. Food and Drug Administration.

Download